L01XG02 carfilzomib
ATC group of level 5 – chemical substance · in plain English: cancer medicines
This site has the patient leaflet or the SPC of 4 medicines in this group.
- 4 prescription only (POM)
Active substance: Carfilzomib – all medicines with this substance, also in combinations.
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L01 Antineoplastic agents 1,025 medicines
- L01X Other antineoplastic agents 225 medicines
- L01XG Proteasome inhibitors, antineoplastic agent 43 medicines
- L01XG02 carfilzomib 4 medicines
- L01XG Proteasome inhibitors, antineoplastic agent 43 medicines
- L01X Other antineoplastic agents 225 medicines
- L01 Antineoplastic agents 1,025 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Kyprolis (Carfilzomib) 10 mg powder for solution for infusion SPC | Prescription only (POM) |
| Kyprolis (Carfilzomib) 30 mg powder for solution for infusion SPC | Prescription only (POM) |
| Kyprolis 10 mg powder for solution for infusion | Prescription only (POM) |
| Kyprolis 30 mg powder for solution for infusion | Prescription only (POM) |
Other groups of the same level
- L01XG01 bortezomib 33 medicines
- L01XG03 ixazomib 6 medicines
Other names of the ATC group
- German: L01XG02 Carfilzomib
- German: L01XG02 Carfilzomib
- Italian: L01XG02 CARFILZOMIB
- Turkish: L01XG02 carfilzomib
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L01XG02
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.